Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects

Fertility and Sterility

Volumn 89, Issue 2 SUPPL., 2008, Pages

  Sharpe, Richard M ^a   Skakkebaek, Niels E ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Rigshospitalet   (Denmark)

Author keywords

anogenital distance; compensated Leydig cell failure; cryptorchidism; fetal germ cells; hypospadias; Leydig cell; low sperm counts; Sertoli cell; Testosterone

Indexed keywords

ANDROGEN; ENVIRONMENTAL CHEMICAL; N (DIBUTYL) PHTHALATE; PHTHALIC ACID; TESTOSTERONE;

ANDROGEN SYNTHESIS; CELL PROLIFERATION; CLINICAL FEATURE; CRYPTORCHISM; ENVIRONMENTAL EXPOSURE; GERM CELL TUMOR; GONADAL DYSGENESIS; HYPOSPADIAS; INCIDENCE; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SERTOLI CELL; SPERMATOZOON COUNT; TESTIS CANCER; TESTIS DEVELOPMENT; TESTIS DISEASE; ANIMAL; CONGENITAL MALFORMATION; HUMAN; MALE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TESTIS;

ANDROGENS; ANIMALS; CRYPTORCHIDISM; HUMANS; HYPOSPADIAS; MALE; TESTIS;

EID: 41749092093     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.12.026     Document Type: Review

References (54)

1. Skakkebæk N.E., Rajpert-De Meyts E., and Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16 (2001) 972-978
2. Sharpe R.M., and Skakkebaek N.E. Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research. Pure Appl Chem 75 (2003) 2023-2038
3. Jorgensen N., Andersen A.G., Eustache F., Irvine D.S., Suominen J., Petersen J.H., et al. Regional differences in semen quality in Europe. Hum Reprod 16 (2001) 1012-1019
4. Boisen K.A., Kaleva M., Main K.M., Virtanen H.E., Haavisto A.-M., Schmidt I.M., et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363 (2004) 1264-1269
5. Boisen K., Chellakooty M., Schmidt I., Kai C., Damgaard I., Suomi A.M., et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at 3 months of age. J Clin Endocrinol Metab 90 (2005) 4041-4046
6. Richiardi L., Bellocco R., Adami H.O., Torrang A., Barlow L., Hakulinen T., et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13 (2004) 2157-2166
7. Main K.M., Toppari J., Suomi A.-M., Kaleva M., Chellakooty M., Schmidt I.M., et al. Larger Testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab 91 (2006) 2732-2737
8. Mylchreest E., Wallace D.G., Cattley R.C., and Foster P.M. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to Di(n-butyl) phthalate during late gestation. Toxicol Sci 55 (2000) 143-151
9. Parks L.G., Ostby J.S., Lambright C.R., Abbott B.D., Klinefelter G.R., Barlow N.J., et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 58 (2000) 339-349
10. Fisher J.S., Macpherson S., Marchetti N., and Sharpe R.M. Human "testicular dysgenesis syndrome": a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod 18 (2003) 1383-1394
11. Mahood I.K., Hallmark N., McKinnell C., Walker M., Fisher J.S., and Sharpe R.M. Abnormal Leydig cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology 146 (2005) 613-623
12. Scott H.M., Hutchison G.R., Mahood I.K., Hallmark N., Welsh M., de Gendt K., et al. Role of androgens in fetal testis development and dysgenesis. Endocrinology 148 (2007) 2027-2036
13. Høi-Hansen C.E., Holm M., Rajpert-De Meyts E., and Skakkebæk N.E. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 200 (2003) 370-374
14. Nistal M., Gonzalez-Peramato P., Regadera J., Serrano A., Tarin V., and De Miguel M.P. Primary testicular lesions are associated with testicular germ cell tumors of adult men. Am J Surg Pathol 30 (2006) 1260-1268
15. Sharpe R.M. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract Res Clin Endocrinol Metab 20 (2006) 91-110
16. Ferrara D., Hallamrk N., Scott H.M., Brown R., McKinnell C., Mahood I.K., et al. Acute and long-term effects of in utero exposure of rats to di(n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology 14 (2006) 5352-5362
17. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12 (2006) 303-323
18. Tan K.A., De Gendt K., Atanassova N., Walker M., Sharpe R.M., Saunders P.T., et al. The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total or Sertoli cell-selective ablation of the androgen receptor. Endocrinology 146 (2005) 2674-2683
19. Atanassova N.N., Walker M., McKinnell C., Fisher J.S., and Sharpe R.M. Evidence that androgens and oestrogens, as well as follicle-stimulating hormone, can alter Sertoli cell number in the neonatal rat. J Endocrinol 184 (2005) 107-117
20. Sharpe R.M., McKinnell C., Kivlin C., and Fisher J.S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125 (2003) 769-784
21. Cortes D., Muller J., and Skakkebaek N.E. Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 10 (1987) 589-596
22. de Gendt K., Atanassova N., Tan K.A.L., Renato de Franca L., Parreira G.G., McKinnell C., et al. Development and function of the adult generation of Leydig cells in mice with Sertoli cell-selective (SCARKO) or total (ARKO) ablation of the androgen receptor. Endocrinology 146 (2005) 4117-4126
23. Wilson V.S., Lambright C., Furr J., Ostby J., Wood C., Held G., et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett 146 (2004) 207-215
24. McKinnell C., Sharpe R.M., Mahood K., Hallmark N., Scott H., Ivell R., et al. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate. Endocrinology 146 (2005) 4536-4544
25. Verp M.S., and Simpson J.L. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 25 (1987) 191-218
26. Hannema S.E., Scott I.S., Rajpert-De Meyts E., Skakkebaek N.E., Colemna N., and Hughes I.A. Testicular development in the complete androgen insensitivity syndrome. J Pathol 208 (2006) 518-527
27. Brennan J., and Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 7 (2004) 509-521
28. Petersen P.M., Giwercman A., Hansen S.W., Berthelsen J.G., Daugaard G., Rorth M., et al. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 17 (1999) 173-179
29. Andersson A.-M., Jorgensen N., Frydelund-Larsen L., Rajpert-De Meyts E., and Skakkebaek N.E. Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab 89 (2004) 3161-3167
30. Huhtaniemi I., and Pelliniemi L.J. Fetal Leydig cells: cellular origin, morphology, life span and special functional features. Proc Soc Exp Biol Med 201 (1992) 125-140
31. Sharpe R.M., Walker M., Millar M.R., Atanassova N., Morris K., McKinnell C., et al. Effect of neonatal gonadotropin-releasing hormone antagonist administration on Sertoli cell number and testicular development in the marmoset: comparison with the rat. Biol Reprod 62 (2000) 1685-1693
32. Travison T.G., Araujo A.B., O'Donnell A.B., Kupeian V., and McKinlay J.B. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92 (2007) 196-202
33. Bergström R., Adami H.-O., Möhner M., Zatonski W., Storm H., Ekbom A., et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88 (1996) 727-733
34. Swan S.H., Elkin E.P., and Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environ Health Perspect 108 (2000) 961-966
35. Cohen-Bendahan C.C., van de Beek C., and Berenbaum S.A. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev 29 (2005) 353-384
36. Auyeung B., Baron-Cohen S., Chapman E., Knickmeyer R., Taylor K., and Hackett G. Foetal testosterone and the child systemizing quotient. Eur J Endocrinol 155 Suppl 1 (2006) S123-S130
37. McIntyre B.S., Barlow N.J., and Foster P.M. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 62 (2001) 236-249
38. Salazar-Martinez E., Romano-Riquer P., Yanez-Marquez E., Longnecker M.P., and Hernandez-Avila M. Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health 3 (2004) 8 [Online 13 September 2004]
39. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113 (2005) 1056-1061
40. van de Beek C., Thijssen J.H., Cohen-Kettenis P.T., van Goozen S.H., and Buitelaar J.K. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure?. Horm Behav 46 (2004) 663-669
41. McGlynn K.A., Devesa S.S., Sigurdson A.J., Brown L.M., Tsao L., and Tarone R.E. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97 (2003) 63-70
42. de Zegher F., Francois I., Boehmer A.L., Saggese G., Muller J., Hiort O., et al. Androgens and fetal growth. Horm Res 50 (1998) 243-244
43. Zaren B., Lindmark G., and Bakketeig L. Maternal smoking affects fetal growth more in the male fetus. Paediatr Perinat Epidemiol 14 (2000) 118-126
44. Storgaard L., Bonde J.P., Ernst E., Spano M., Andersen C.Y., Frydenberg M., et al. Does smoking during pregnancy affect sons' sperm counts?. Epidemiology 14 (2003) 278-286
45. Jensen T.K., Jorgensen N., Punab M., Haugen T.B., Suominene J., Zilaitene B., et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1770 young men from the general population in five European countries. Am J Epidemiol 159 (2004) 49-58
46. Carlsen S.M., Jacobsen G., and Romundsatd P. Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol 155 (2006) 365-370
47. Manikkam M., Crespi E.J., Doop D.D., Herkimer C., Lee J.S., Yu S., et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145 (2004) 790-798
48. Seckl J.R., and Meaney M.J. Glucocorticoid programming. Ann NY Acad Sci 1032 (2004) 63-84
49. Main K.M., Mortensen G.K., Kaleva M., Boisen K., Damgaard I., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in three months old infants. Environ Health Perspect 114 (2006) 270-276
50. Hardell L., van Bavel B., Lindstrom G., Eriksson M., and Carlberg M. In utero exposure to persistent organic pollutants in relation to testicular cancer risk. Int J Androl 29 (2006) 228-234
51. Hotchkiss A.K., Parks-Saldutti L.G., Ostby J.S., Lambright C., Furr J., Vandenbergh J.G., et al. A mixture of the "antiandrogens" linuron and butyl benzyl phthalate alters sexual differentiation of the male rat in a cumulative fashion. Biol Reprod 71 (2004) 1852-1861
52. Hass U., Scholze M., Christiansen S., Dalgaard M., Vinggaard A., Axelstad M., et al. Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environ Health Perspect (2007) 115 (Suppl 1):122-8
53. Jørgensen N., Asklund C., Carlsen E., and Skakkebæk N.E. Coordinated European investigations of semen quality: results from studies of Scandinavian young men is a matter of concern. Int J Androl 29 (2006) 54-61
54. Bray F., Richiardi L., Ekbom A., Pukkala E., Cuninkova M., and Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118 (2006) 3099-3111